Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Parkinson's Disease

Free Subscription 09.02.2026 1 Am J Pathol 1 Biochemistry 1 BMC Neurol 1 Brain Res 1 Exp Neurol 1 J Neural Transm (Vienna) 1 J Neurochem 1 J Neurosci 4 Mov Disord 2 Nature 4 Neurobiol Dis 1 Neuroscience 3 Proc Natl Acad Sci U S A 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. NELSON CA, Obray JD, Roll CR, Williams PE, et al
   Leukocytic Dopamine D2 Receptors as Biomarkers for Brain Dopamine Levels in Parkinson's Disease.
   Am J Pathol. 2026 Feb 1:S0002-9440(26)00028-3. doi: 10.1016/j.ajpath.2026.
   PubMed         Abstract available
   
   

   
   Biochemistry

2. DEVI M, Paul S
   Precision Interdiction of alpha-Synuclein Folding Pathways by Molecular Tweezers.
   Biochemistry. 2026;65:325-338.
   PubMed         Abstract available
   
   

   
   BMC Neurol

3. ZANG P, Liu Y, Hao Y
   Levodopa intolerance as a potential clinical red flag for neuronal intranuclear inclusion disease (NIID) in atypical parkinsonism: a case report.
   BMC Neurol. 2026 Feb 3. doi: 10.1186/s12883-026-04696.
   PubMed         Abstract available
   
   

   
   Brain Res

4. CAVALCANTI BEZERRA GOUVEIA HJ, Dos Santos-Junior OH, Frasnelli J, Fisette A, et al
   Ghrelin-based interventions in preclinical models of Parkinson's disease: a systematic review.
   Brain Res. 2026;1876:150187.
   PubMed         Abstract available
   
   

   
   Exp Neurol

5. WANG L, Wang Y, Yang S, Bai Y, et al
   Long-term continuous theta burst stimulation ameliorates L-DOPA-induced dyskinesia in Parkinsonian rats through modulation of the cerebello-thalamo-striatal circuit.
   Exp Neurol. 2026;399:115674.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

6. METTA V, Mridula R, Hosurkar G, Wadia P, et al
   Deep brain stimulation for Parkinson's disease in India: an expert consensus on availability, affordability, and eligibility by the Parkinson's research alliance India (PRAI).
   J Neural Transm (Vienna). 2026 Feb 3. doi: 10.1007/s00702-026-03106.
   PubMed        
   
   

   
   J Neurochem

7. LEE HS, Kang SA, Eom JW, Kim MS, et al
   Zinc-Mediated Lysosomal Destabilization Links Mitochondrial Damage to Neuronal Death in a Cellular MPP(+) Model of Parkinson's Disease.
   J Neurochem. 2026;170:e70363.
   PubMed         Abstract available
   
   

   
   J Neurosci

8. ARMAKOLA M, Wilen AP, Bustos BI, Song P, et al
   In vivo screen of Parkinson's disease GWAS risk genes identifies ARIH2 as a novel regulator of alpha-synuclein toxicity in dopaminergic neurons.
   J Neurosci. 2026 Feb 6:e0509252026. doi: 10.1523/JNEUROSCI.0509-25.2026.
   PubMed         Abstract available
   
   

   
   Mov Disord

9. RAJAI FIROUZABADI S, Mohammadi I, Golsorkh H, Mahdavi S, et al
   Hearing Loss in Parkinson's Disease: A Systematic Review and Meta-Analysis.
   Mov Disord. 2026 Jan 30. doi: 10.1002/mds.70206.
   PubMed         Abstract available
   
   
10. NIEMI KJ, Kaasinen V, Weil RS, Joutsa J, et al
    Monoaminergic Networks of Cognitive and Behavioral Symptoms in Early Parkinson's Disease.
    Mov Disord. 2026 Jan 30. doi: 10.1002/mds.70199.
    PubMed         Abstract available
    
    
11. KOFOED RH, Hvingelby VS, Pineda-Pardo JA, Blesa J, et al
    Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson's Disease.
    Mov Disord. 2026 Feb 3. doi: 10.1002/mds.70156.
    PubMed         Abstract available
    
    
12. DARDOV VJ, Vasanthakumar A, Kulkarni A, Sundararaman N, et al
    Accelerating Medicines Partnership(R) Parkinson's Disease Proteomics: A Comprehensive Resource for Advancing Parkinson's Disease Research.
    Mov Disord. 2026 Feb 5. doi: 10.1002/mds.70183.
    PubMed         Abstract available
    
    

    
    Nature

13. BAEKELANDT V
    Immune cells from the gut drive development of Parkinson's disease in the brain.
    Nature. 2026 Feb 4. doi: 10.1038/d41586-026-00284.
    PubMed        
    
    
14. REN J, Zhang W, Dahmani L, Gordon EM, et al
    Parkinson's disease as a somato-cognitive action network disorder.
    Nature. 2026 Feb 4. doi: 10.1038/s41586-025-10059.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

15. ZHENG Q, Lin X, Fei G, Xiao L, et al
    A neuropeptide receptor-enriched transcriptional state characterizes resilient dopaminergic neurons in Parkinson's disease.
    Neurobiol Dis. 2026;220:107303.
    PubMed         Abstract available
    
    
16. ATHIENITI E, Afxenti S, Minadakis G, Spyrou GM, et al
    Multi-omics dissection of Parkinson's patients in subgroups associated with motor and cognitive severity.
    Neurobiol Dis. 2026 Feb 2:107288. doi: 10.1016/j.nbd.2026.107288.
    PubMed         Abstract available
    
    
17. CUI J, Zhao D, Liu J, Qian J, et al
    Inhibition of the LHb glutamatergic pathway ameliorates depressive-like behaviors in a 6-hydroxydopamine-induced Parkinson's disease mouse model.
    Neurobiol Dis. 2026;220:107293.
    PubMed         Abstract available
    
    
18. ROTH LM, Morozova O, Stohr J, Schapansky J, et al
    Astrocytic lysosome deficits reduce alpha-synuclein degradation and induce the spread of pathology.
    Neurobiol Dis. 2026;219:107277.
    PubMed         Abstract available
    
    

    
    Neuroscience

19. CALZETTI S, Negrotti A
    Dopamine antagonists-induced parkinsonism: the crucial role of individual susceptibility associated to positive family history.
    Neuroscience. 2026 Jan 31:S0306-4522(26)00079.
    PubMed        
    
    

    
    Proc Natl Acad Sci U S A

20. 
    Correction Paschou et al., Dysregulated proteostasis in p.A53T-alpha-Synuclein astrocytes aggravates Lewy-like neuropathology in a Parkinson's disease iPSC model.
    Proc Natl Acad Sci U S A. 2026;123:e2601834123.
    PubMed        
    
    
21. OLCHANYI MD, Schreier DR, Li J, Maffei C, et al
    Probabilistic mapping and automated segmentation of human brainstem white matter bundles.
    Proc Natl Acad Sci U S A. 2026;123:e2509321123.
    PubMed         Abstract available
    
    
22. WRIGHT S, Dang VC, Hussain S, Kandel P, et al
    Selective peroxynitrite-mediated protein nitration catalyzed by glyoxalase domain containing protein 4.
    Proc Natl Acad Sci U S A. 2026;123:e2515002123.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

23. TRAN HT, Huynh MBT
    Reliability and validity of the Vietnamese version of the Montreal Cognitive Assessment in Parkinson's disease.
    Rev Neurol (Paris). 2026 Feb 3:S0035-3787(26)00022.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum